Search results
2 Magnificent Dividend Stocks to Hold for the Next Decade
Motley Fool via Yahoo Finance· 6 hours agoNovartis (NYSE: NVS) and Visa (NYSE: V). 1. Novartis What makes a drugmaker like Novartis a great...
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Market Watch· 4 days agoPharmaceutical giant Novartis AG on Thursday said it will pay up to $1.75 billion for a U.S. biotech...
Novartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business
Morningstar· 4 days agoBy Mauro Orru Novartis agreed to acquire U.S. biotechnology company Mariana Oncology for up to $1.75 billion, in a deal that bolsters its radioligand therapy pipeline and ...
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
BioPharma Dive via Yahoo Finance· 3 days agoNovartis currently sells two approved radiopharmaceuticals, Pluvicto and Lutathera. Their success...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 4 days agoNovartis AG (NYSE:NVS) is one of the largest pharmaceutical companies in the world, many of whose drugs are "gold standards" in the treatment of cancer,...
Questor: this medical stock is expensive – but worth paying for
The Telegraph via Yahoo Finance· 5 hours agoIt’s a stock market rule of thumb that big acquisitions tend to destroy shareholder value....
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 2 days agoThat distinguishes its deal with Novartis from other recent acquisitions of RayzeBio by Bristol Myers Squibb and of Fusion Pharmaceuticals by AstraZeneca...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 4 days agoLast year, major pharmaceutical companies heavily invested in R&D, with expenditure ranging from around 14% to 50% of their revenues. Some of the...
Novartis pays PeptiDream $180M as radiopharma big bang continues
FierceBiotech· 6 days agoNovartis is pumping another $180 million into its radioligand plan, handing the cash to serial dealmaker PeptiDream to expand (PDF) a peptide-drug conjugate (PDC) collaboration ...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 5 days agoAlso on the list are inhalers and more diabetes treatments from AstraZeneca Boehringer Ingelheim,...
